A Novel Form of 4-1bbl Has Better Immunomodulatory Activity Than an Agonistic Anti-4-1bb Ab Without Ab-Associated Severe Toxicity
Vaccine - Netherlands
doi 10.1016/j.vaccine.2009.09.127
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2009
Authors
Publisher
Elsevier BV